Conference on personalised cancer therapy

Barcelona: 3-4 December 2012

The organisers of the IDIBELL Cancer Conference (ICC) on Personalized Cancer Medicine – Manel Esteller, George Thomas, Cristina Muñoz- Pinedo and Sara Kozma – will present 21speakers for the event, all leading oncologists and cancer researchers, particularly those working in the study of genetic and epigenetic defects leading to the selection of cancer patients for new drug therapies. The meeting aims to highlight the latest understanding of biological mechanisms and natural history of cancer, thus providing novel targets for therapy, as well as to discuss the molecular mechanisms involved in the stratification of oncology patents according to the recently described molecular markers. Special focus: Epigenetics and DNA Repair and the metabolism and cell signalling areas with the updated clinical applications. Details: http://bocemtium.com

05.11.2012

News • Differentiation after radiotherapy

Brain tumour or radiation necrosis? AI can tell them apart

A novel AI-based method can distinguish between progressive brain tumours and radiotherapy-induced necrosis on advanced MRI. This could help clinicians more accurately identify and treat the issues.

News • CAR-T and BITEs

At-home monitoring safely cuts hospital time after T-cell redirecting therapy

After T-cell redirecting therapies, patients are typically hospitalized for several days to watch for side effects. New research shows that these patients can safely be monitored at home.

News • Malignant melanoma

Immunotherapy for skin cancer: when less is more

New immunotherapies are effective against skin cancer, but they can cause serious side effects. New insights suggest that a lower dosage may lead to better outcomes and longer survival.